Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2016, Article ID 7984576, 6 pages
http://dx.doi.org/10.1155/2016/7984576
Clinical Study

Twelve-Month Follow-Up of Dexamethasone Implants for Macular Edema from Various Diseases in Vitrectomized and Nonvitrectomized Eyes

1Department of Ophthalmology, Federal University of São Paulo, São Paulo, SP, Brazil
2Brazilian Institute of Fighting Against Blindness (INBRACE), Assis/Presidente Prudente, SP, Brazil
3Federal University of Goiás, Goiânia, GO, Brazil
4Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA
5Asociados de Macula Vitreo y Retina de Costa Rica, San Jose, Costa Rica
6University of Puerto Rico, San Juan, PR, USA

Received 11 June 2016; Accepted 28 August 2016

Academic Editor: Enrico Peiretti

Copyright © 2016 Eduardo A. Novais et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. O. Tomkins-Netzer, F. Ismetova, A. Bar, S. Seguin-Greenstein, M. Kramer, and S. Lightman, “Functional outcome of macular edema in different retinal disorders,” Progress in Retinal and Eye Research, vol. 48, pp. 119–136, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. T. J. Wolfensberger and Z. J. Gregor, “Macular edema—rationale for therapy,” Developments in Ophthalmology, vol. 47, pp. 49–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J. A. Haller, “Current anti-vascular endothelial growth factor dosing regimens: benefits and burden,” Ophthalmology, vol. 120, supplement 5, pp. S3–S7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. V. Sarao, D. Veritti, F. Boscia, and P. Lanzetta, “Intravitreal steroids for the treatment of retinal diseases,” The Scientific World Journal, vol. 2014, Article ID 989501, 14 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J.-E. Chang-Lin, M. Attar, A. A. Acheampong et al., “Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant,” Investigative Ophthalmology and Visual Science, vol. 52, no. 1, pp. 80–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Yanyali, B. Aytug, F. Horozoglu, and A. F. Nohutcu, “Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes,” American Journal of Ophthalmology, vol. 144, no. 1, pp. 124–126, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Dutra Medeiros, M. Postorino, R. Navarro, J. Garcia-Arumí, C. Mateo, and B. Corcóstegui, “Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema,” Ophthalmologica, vol. 231, no. 3, pp. 141–146, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. D. S. Boyer, D. Faber, S. Gupta et al., “Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients,” Retina, vol. 31, no. 5, pp. 915–923, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. D. S. Boyer, Y. H. Yoon, R. Belfort et al., “Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema,” Ophthalmology, vol. 121, no. 10, pp. 1904–1914, 1904. View at Publisher · View at Google Scholar
  10. J. A. Haller, F. Bandello, R. Belfort Jr. et al., “Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results,” Ophthalmology, vol. 118, no. 12, pp. 2453–2460, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Bezatis, G. Spital, F. Höhn et al., “Functional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up—the SOLO study,” Acta Ophthalmologica, vol. 91, no. 5, pp. e340–e347, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Tomkins-Netzer, S. R. J. Taylor, A. Bar et al., “Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis,” Ophthalmology, vol. 121, no. 8, pp. 1649–1654, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Zalewski, D. Raczyńska, and K. Raczyńska, “Five-month observation of persistent diabetic macular edema after intravitreal injection of ozurdex implant,” Mediators of Inflammation, vol. 2014, Article ID 364143, 4 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. I. Zucchiatti, R. Lattanzio, G. Querques et al., “Intravitreal dexamethasone implant in patients with persistent diabetic macular edema,” Ophthalmologica, vol. 228, no. 2, pp. 117–122, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. D. Medeiros, M. Alkabes, R. Navarro, J. Garcia-Arumí, C. Mateo, and B. Corcóstegui, “Dexamethasone intravitreal implant in vitrectomized versus nonvitrectomized eyes for treatment of patients with persistent diabetic macular edema,” Journal of Ocular Pharmacology and Therapeutics, vol. 30, no. 9, pp. 709–716, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. W.-C. Lam, D. A. Albiani, P. Yoganathan et al., “Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study,” Clinical Ophthalmology, vol. 9, pp. 1255–1268, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Capone Jr., M. A. Singer, D. G. Dodwell et al., “Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study),” Retina, vol. 34, no. 2, pp. 342–351, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. S. J. Ahn, J. Ahn, S. Park et al., “Intraocular pharmacokinetics of ranibizumab in vitrectomized versus nonvitrectomized eyes,” Investigative Opthalmology & Visual Science, vol. 55, no. 1, pp. 567–573, 2014. View at Google Scholar
  19. J. B. Christoforidis, M. M. Williams, J. Wang et al., “Anatomic and pharmacokinetic properties of intravitreal bevacizumab and ranibizumab after vitrectomy and lensectomy,” Retina, vol. 33, no. 5, pp. 946–952, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Kakinoki, O. Sawada, T. Sawada, Y. Saishin, H. Kawamura, and M. Ohji, “Effect of vitrectomy on aqueous VEGF concentration and pharmacokinetics of bevacizumab in macaque monkeys,” Investigative Ophthalmology & Visual Science, vol. 53, no. 9, pp. 5877–5880, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. H.-S. Chin, T.-S. Park, Y.-S. Moon, and J.-H. Oh, “Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes,” Retina, vol. 25, no. 5, pp. 556–560, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Pelegrín, M. S. De La Maza, B. Molins, J. Ríos, and A. Adán, “Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis,” Eye, vol. 29, no. 7, pp. 943–950, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Petrash, “Aging and age-related diseases of the ocular lens and vitreous body,” Investigative Ophthalmology and Visual Science, vol. 54, no. 14, pp. ORSF54–ORSF59, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Bhatnagar, W. M. Schiff, and G. R. Barile, “Diabetic vitrectomy: the influence of lens status upon surgical outcomes,” Current Opinion in Ophthalmology, vol. 19, no. 3, pp. 243–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Lowder, R. Belfort Jr., S. Lightman et al., “Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis,” Archives of Ophthalmology, vol. 129, no. 5, pp. 545–553, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. A. Haller, F. Bandello, R. Belfort Jr. et al., “Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion,” Ophthalmology, vol. 117, no. 6, pp. 1134–1146.e3, 2010. View at Publisher · View at Google Scholar · View at Scopus